Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Liver surgery showdown: which method spares the heart?

NCT ID NCT06895798

Knowledge-focused Sponsor: Beijing Tsinghua Chang Gung Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 1,286 older adults or those with heart risks undergoing major liver surgery. It compared two methods of controlling blood flow to the liver to see which one causes less heart injury after surgery. The goal is to find safer surgical approaches and identify risk factors to prevent heart complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,286 people

The number who actually took part.

Started

Mar 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

As of February 2024, patients ≥ 65 years old, or ≥ 45 years old with cardiovascular risk factors (especially known cardiovascular disease), who have undergone or are scheduled to undergo elective major hepatopancreatobiliary surgery under general anesthesia are being recruited/enrolled.

Ages

45 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 65 years, or ≥ 45 years with cardiovascular risk factors (especially known cardiovascular disease). * Undergoing elective major hepatopancreatobiliary surgery under general anesthesia. * ASA physical status II-III. * Provide written informed consent to participate in the study (applicable to the prospective cohort). Exclusion Criteria: * Emergency surgery * Preoperative diagnosis of myocardial infarction or unstable angina * Severe hepatic insufficiency (Child-Pugh class C) * Concomitant severe organ dysfunction (e.g., renal failure, respiratory failure) * Concomitant active infectious disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ischemia reperfusion injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ischemia reperfusion injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ischemia reperfusion injury Myocardial injury after non-cardiac surgery

Contacts and locations

Locations

  • Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine，Tsinghua University

    Beijing, Beijing Municipality, 102218, China

  • Peking University International Hospital

    Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.